Leonard A. Smith

Development of vaccines for prevention of botulism.

L. Smith, M. P. Byrne, Michael P. Byrne, 2000, Biochimie.

Modeling Pichia pastoris growth on methanol and optimizing the production of a recombinant protein, the heavy-chain fragment C of botulinum neurotoxin, serotype A.

W. Zhang, L. Smith, M. Meagher, 2000, Biotechnology and bioengineering.

Fermentation, purification, and efficacy of a recombinant vaccine candidate against botulinum neurotoxin type F from Pichia pastoris.

R. Titball, R. Titball, L. Smith, 2000, Protein expression and purification.

Innocuous full-length botulinum neurotoxin targets and promotes the expression of lentiviral vectors in central and autonomic neurons

S. Ovsepian, L. Smith, V. O'Leary, 2011, Gene Therapy.

Light Chain Separated from the Rest of the Type A Botulinum Neurotoxin Molecule Is the Most Catalytically Active Form

Leonard A. Smith, S. Ahmed, N. Gul, 2010, PloS one.

Expression, purification, and efficacy of the type A botulinum neurotoxin catalytic domain fused to two translocation domain variants.

L. Smith, T. Smith, S. Ahmed, 2003, Toxicon : official journal of the International Society on Toxinology.